Publicaciones en revistas
- Frontal Cortex Lipid Alterations During the Onset of Alzheimer's Disease. Journal of Alzheimer's Disease, 2024; 98(4), 1515 - 1532 - 1387-2877
- Neuroanatomical characterization of the G protein-coupled receptor activity evoked by galanin-related ligands J Chem Neuroanat, 2023; 128, 102226. - - - 1873-6300
- Microarrays, Enzymatic Assays, and MALDI-MS for Determining Specific Alterations to Mitochondrial Electron Transport Chain Activity, ROS Formation, and Lipid Composition in a Monkey Model of Parkinson's Disease Int J Mol Sci (Q1), 2023; 24(6), 5470 - - - 1422-0067
- Cannabinoid Receptors and Glial Response Following a Basal Forebrain Cholinergic Lesion ACS Pharmacol Transl Sci (Q1), 2022; 5, 9, 791 - 802 - 2575-9108
- Handling and novel object recognition modulate fear response and endocannabinoid signaling in nucleus basalis magnocellularis Eur J Neurosci, 2022; 55(6), 1532 - 1546 - 0953-816X
- Specific Phospholipid Modulation by Muscarinic Signaling in a Rat Lesion Model of Alzheimer's Disease ACS Chemical Neuroscience (Q1), 2021; 12 (12), 2167 - 2181 - 1948-7193
- : Pharmacological ablation of astrocytes reduces Aβ degradation and synaptic connectivity in an ex vivo model of Alzheimer's disease. J Neuroinflammation, 18(1):73, 2021
- Modulation of Neurolipid Signaling and Specific Lipid Species in the Triple Transgenic Mouse Model of Alzheimer's Disease Int J Mol Sci (1), 2021; 22(22): 12256
- Chronic central modulation of LPA/LPA receptors-signaling pathway in the mouse brain regulates cognition, emotion, and hippocampal neurogenesis. Prog Neuropsychopharmacol Biol Psychiatry., 2020; Nov 2:110156
- ACE2 activators for the treatment of COVID 19 patients. J Med Virol., 2020; 92(10):1701-1702.
—
10 Resultados por página